BioCentury
ARTICLE | Company News

Opko acquiring Prolor

April 25, 2013 12:01 AM UTC

Opko Health Inc. (NYSE:OPK) will acquire Prolor Biotech Inc. (NYSE-M:PBTH; Tel Aviv:PBTH) in a stock deal that the companies said values Prolor at about $480 million. Under the deal, Prolor shareholders will receive 0.9951 Opko shares for every Prolor share held. The deal, which has been approved by the boards of both companies and is subject to shareholder approval, is slated to close in 2H13. Barrington Research Associates is advising Opko Health. Jefferies is advising Prolor. ...